Common Contracts
1 similar null contracts
ContractAugust 16th, 2024
AMENDMENT NO. 1 TO CLINICLA TRIAL AGREEMENT DODATEK Č. 1 KE SMLOUVĚ O KLINICKÉM HODNOCENÍ This Amendment no. 1 (“Amendment”), valid as of last date of signature by and between Apellis Pharmaceuticals, Inc., a Delaware corporation with an office at 100 5th Avenue, Waltham MA 02451, USA (“Sponsor” or “Apellis”), Fortrea Inc. (formerly known as Labcorp), 8 Moore Drive, Durham, NC 27709 USA and its affiliates, represented by(hereinafter referred to as “Fortrea”) and Fakultní nemocnice Královské Vinohrady, with seat at Šrobárova 1150/50, 100 34 Praha 10, Czech Republic, Id No.: 00064173, tax Id No.: CZ00064173, represented by, reference number: KH 44/2021, cost center: 43075 (hereinafter referred to as the “Institution”), and MUDr. Miroslav Veith, Ph.D., date of birth, with address at, Czech Republic, doctor ofFakultní nemocnice Královské Vinohrad (“Investigator”). All capitalized terms not otherwise defined herein shall retain the meaning attributed to them in the Agreement, as defined
